Lingxia Pang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Physiology top 10%
- Adipose Tissue and Metabolism
Papers in
-
- Circular RNAs in diseases 6
- Wnt/β-catenin signaling in development and cancer 2
- RNA Research and Splicing 2
- Fibroblast Growth Factor Research 2
-
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 9
- Co-authors
- Xirong Guo (14 shared papers)Chenbo Ji (14 shared papers)Chunmei Shi (10 shared papers)Lei Yang (8 shared papers)Ling Chen (6 shared papers)Guangfeng Xu (3 shared papers)Yuhui Ni (3 shared papers)Ling Chen (3 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (2 papers)Scientific Reports (2 papers)Cardiovascular Drugs and Therapy (1 paper)Materials Today Bio (1 paper)Frontiers in Endocrinology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Lingxia Pang
32 papers receiving 768 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 353
- Physiology 177
- Molecular Biology 346
- Rehabilitation 30
- Epidemiology 148
Countries citing papers authored by Lingxia Pang
This map shows the geographic impact of Lingxia Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingxia Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingxia Pang more than expected).
Fields of papers citing papers by Lingxia Pang
This network shows the impact of papers produced by Lingxia Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingxia Pang. The network helps show where Lingxia Pang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingxia Pang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 153 | |
| 2 | 2014 | 99 | |
| 3 | 2014 | 92 | |
| 4 | Bone marrow mesenchymal stem cells protect against bleomycin-induced pulmonary fibrosis in rat by activating Nrf2 signaling. | 2015 | 42 |
| 5 | 2016 | 40 | |
| 6 | 2014 | 33 | |
| 7 | 2014 | 29 | |
| 8 | 2014 | 28 | |
| 9 | 2016 | 27 | |
| 10 | 2018 | 25 | |
| 11 | 2016 | 24 | |
| 12 | 2013 | 24 | |
| 13 | 2014 | 22 | |
| 14 | 2020 | 18 | |
| 15 | 2016 | 18 | |
| 16 | 2020 | 14 | |
| 17 | 2019 | 13 | |
| 18 | 2018 | 13 | |
| 19 | 2018 | 13 | |
| 20 | Application of citrate as a tricarboxylic acid (TCA) cycle intermediate, prevents diabetic-induced heart damages in mice. | 2016 | 7 |
About Lingxia Pang
Lingxia Pang is a scholar working on Molecular Biology, Cancer Research, Physiology, Epidemiology and Surgery, having authored 32 papers that have together received 771 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (6 papers), Adipose Tissue and Metabolism (6 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers), Wnt/β-catenin signaling in development and cancer (2 papers), RNA Research and Splicing (2 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Cancer Research (353 citations), Physiology (177 citations), Molecular Biology (346 citations), Rehabilitation (30 citations) and Epidemiology (148 citations). Lingxia Pang has collaborated with scholars based in China and United States. Frequent co-authors include Xirong Guo, Chenbo Ji, Chunmei Shi, Lei Yang, Ling Chen, Guangfeng Xu, Yuhui Ni, Ling Chen, Xia Chi and Xianwei Cui. Their work appears in journals such as Biochemical and Biophysical Research Communications, Scientific Reports, Cardiovascular Drugs and Therapy, Materials Today Bio and Frontiers in Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.